Preoperative and Postoperative transcatheter arterial chemoembolization for Resectable Multinodular Hepatocellular Carcinoma: a Prospective Cohort Study

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-09000608

Enrollment

Unknown

Registered

2009-12-07

Start date

2009-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Group A:Conventional operation

50:TACE

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 18-70 years old, male or female; 2. Diagnosis is "hepatocellular carcinoma(HCC)"; 3. Patients should have good health condition and no server damage of the heart, lung or kidney function or extrahepatic metabasis; 4. Liver function is Child-Pugh A; 5. 2 or 3 tumor nodules can be seen by imageology (ultrasound, CT scan or MRI) and can be resected. There is no tumor embolus in the blood vessel or bile duct.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients cannot be in hospital; 2. Patients are not willing to receive surgical resection or TACE. Quit criteria: 1. Patients are in poor compliance, cannot return on time; 2. Patients died within 4-6 weeks after operation or TACE.

Design outcomes

Primary

Measure	Time frame
Over-all survival;Disease-free survival;	—

Countries

China

Contacts

Public ContactLiang Huang

hhll1975@163.com02181875503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026